SOFWF (Sofwave Medical) Research & Development: $13.48 Mil (TTM As of Mar. 2026)


SOFWF Sofwave Medical Ltd SOFWF
48 GF Score
Price $16.00
GF Value $11.23
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sofwave Medical Research & Development?

Sofwave Medical SOFWF 48 Research & Development is $13.48 Mil as of Mar. 2026. GuruFocus rates SOFWF with a GF Score™ of 48/100 and a GF Value™ of $11.23 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sofwave Medical's Research & Development for the three months ended in Mar. 2026 was $3.77 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $13.48 Mil.

Sofwave Medical  (OTCPK:SOFWF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sofwave Medical Research & Development Related Terms

Sofwave Medical Research & Development Historical Data

* Premium members only.

The historical data trend for Sofwave Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sofwave Medical Research & Development Chart

Sofwave Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 8.24 12.44 11.43 10.77 12.80

Sofwave Medical Quarterly Data
Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.09 2.82 3.16 3.74 3.77
SOFWF
48GF Score
Sofwave Medical Ltd SOFWF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sofwave Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $13.48 Mil mean?
Sofwave Medical (SOFWF) has a Research & Development of $13.48 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Sofwave Medical and its competitors.
Is Sofwave Medical's Research & Development too high?
Sofwave Medical's current Research & Development is $13.48 Mil. Overall, Sofwave Medical has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's Research & Development compare to ABT and SYK?
Sofwave Medical's Research & Development of $13.48 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sofwave Medical and its competitors. Sofwave Medical's current Research & Development is $13.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.23, compared to a current price of $16.00 — trading 42.5% above its estimated fair value. The current Research & Development is $13.48 Mil. Sofwave Medical's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current Research & Development is $13.48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sofwave Medical (SOFWF) Overvalued in 2026?

Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued. The current stock price of $16.00 is trading 42.5% above its estimated GF Value™ of $11.23. GuruFocus considers Sofwave Medical to be Significantly Overvalued.

Key valuation signals for SOFWF:

  • Research & Development: $13.48 Mil
  • GF Value™: $11.23 vs. price of $16.00 (42.5% above fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sofwave Medical Business Description

Other Exchanges SOFW:Israel
Address Oak Medtech, Tavor, Alon Medtech Venture, Yokneam Illit, ISR, 2069200
Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.
48GF Score

Get the complete analysis for SOFWF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.00
Price
$11.23
GF Value